Effectiveness of brahmi nei for autism children

An open non randomized single arm single centric clinical trial to determine the effectiveness of Brahmi nei (Internal) for Maantha Sanni (Autism Spectrum Disorder) in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045196

Enrollment

Registered

2022-09-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: Brahmi Nei: 3-7 years- 3 ml,8-12 years- 4.5 ml Bd with milk, Duration - 48 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed as Autism spectrum disorder. Meet the diagnostic symptoms of poor eye contact, inappropriate emotional response, acquired speech or lost it, engaging in stereotyped behavior, and unusual sensitivity to sensory stimuli.

Exclusion criteria

Exclusion criteria: 1. H/O ADHD 2. H/O Seizure and Epilepsy 3. H/O Cerebral Palsy 4. H/O Hearing and Visual Impairments 5. H/O Congenital Anamolies 6. Any other serious illness

Design outcomes

Primary

Measure	Time frame
Improvement in the clinical symptoms after treatment.Timepoint: Screening - 3 months Patient Enrolment - 3 months Trial Drug - 4 months Data Analysis - 1 month Follow up - 1 month	—

Secondary

Measure	Time frame
NILTimepoint: NOT APPLICABLE	—

Countries

India

Contacts

Public ContactDr M Meenakshi Sundaram MDS PhD

National Institute of Siddha

mmssiddha@gmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026